Skip to main content

and
  1. Article

    Open Access

    The use of synaptic biomarkers in cerebrospinal fluid to differentiate behavioral variant of frontotemporal dementia from primary psychiatric disorders and Alzheimer’s disease

    Lack of early molecular biomarkers in sporadic behavioral variants of frontotemporal dementia (bvFTD) and its clinical overlap with primary psychiatric disorders (PPD) hampers its diagnostic distinction. Synap...

    Shreyasee Das, Marie-Paule E. van Engelen, Julie Goossens in Alzheimer's Research & Therapy (2024)

  2. Article

    Open Access

    Cerebrospinal fluid proteomics in patients with Alzheimer’s disease reveals five molecular subtypes with distinct genetic risk profiles

    Alzheimer’s disease (AD) is heterogenous at the molecular level. Understanding this heterogeneity is critical for AD drug development. Here we define AD molecular subtypes using mass spectrometry proteomics in...

    Betty M. Tijms, Ellen M. Vromen, Olav Mjaavatten, Henne Holstege in Nature Aging (2024)

  3. Article

    Open Access

    Evaluation of cerebrospinal fluid levels of synaptic vesicle protein, VAMP-2, across the sporadic Alzheimer’s disease continuum

    Synapse loss is an early event that precedes neuronal death and symptom onset and is considered the best neuropathological correlate of cognitive decline in Alzheimer’s disease (AD). Vesicle-associated membran...

    Julie Goossens, Alba Cervantes González, Nele Dewit in Alzheimer's Research & Therapy (2023)

  4. Article

    Open Access

    Synaptic biomarkers in the cerebrospinal fluid associate differentially with classical neuronal biomarkers in patients with Alzheimer’s disease and frontotemporal dementia

    Loss of synaptic functionality has been recently identified as an early-stage indicator of neurological diseases. Consequently, monitoring changes in synaptic protein levels may be relevant for observing disea...

    Shreyasee Das, Julie Goossens, Dirk Jacobs, Nele Dewit in Alzheimer's Research & Therapy (2023)

  5. Article

    Open Access

    P-tau subgroups in AD relate to distinct amyloid production and synaptic integrity profiles

    We previously identified four Alzheimer’s disease (AD) subgroups with increasingly higher cerebrospinal fluid (CSF) levels of tau phosphorylated at threonine 181 (p-tau). These subgroups included individuals a...

    Kirsten E. J. Wesenhagen, Betty M. Tijms, Lynn Boonkamp in Alzheimer's Research & Therapy (2022)

  6. Article

    Open Access

    Development of a Nanobody-based lateral flow assay to detect active Trypanosoma congolense infections

    Animal African trypanosomosis (AAT), a disease affecting livestock, is caused by parasites of the Trypanosoma genus (mainly T. vivax and T. congolense). AAT is widespread in Sub-Saharan Africa, where it continues...

    Joar E. Pinto Torres, Julie Goossens, Jianzu Ding, Zeng Li in Scientific Reports (2018)